Best Practice & Research Clinical Haematology
Volume 19, Issue 3 , Pages 535-569, September 2006

Eosinophilic disorders: Molecular pathogenesis, new classification, and modern therapy

  • Jason Gotlib

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 650 736 1253; Fax: +1 650 724 5203.

Stanford Cancer Center, 875 Blake Wilbur Drive, Room 2327B, Stanford, CA 94305-5821, USA

Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, SP2 8BJ, UK

Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA and Brigham and Women's Hospital, Boston, MA 02115, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(05)00100-3

doi:10.1016/j.beha.2005.07.013

Best Practice & Research Clinical Haematology
Volume 19, Issue 3 , Pages 535-569, September 2006

Article Tools

* Image Usage & Resolution